Search research articles
Contact Us
Filters
Showing results (91-100 of 102) with videos related to
Page
of 11
Sort By:
Oncology Reports
|
May 9, 2015
Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer
Zhaojin Yu, Mingli Sun, Feng Jin, et al.
Chemical Science
|
September 2, 2025
Enhancing photoredox catalysis by suppressing back electron transfer with the aid of a spin catalyst
Zhiqiang Dong, Chenli Chen, Lingfang Chen, et al.
Molecular Carcinogenesis
|
January 28, 2014
DNA methyltransferase 1/3a overexpression in sporadic breast cancer is associated with reduced expression of estrogen receptor-alpha/breast cancer susceptibility gene 1 and poor prognosis
Zhaojin Yu, Qinghuan Xiao, Lin Zhao, et al.
Nature Communications
|
November 18, 2025
Cross-regional real-time visualization of systemic physiology and dynamics with 3D panoramic photoacoustic computed tomography (3D-PanoPACT)
Xuanhao Wang, Yuqian Meng, Mingli Sun, et al.
Frontiers in Pharmacology
|
September 15, 2025
Pharmacokinetics and safety of highly variable nitroglycerin lingual spray (NLS) versus US-licensed nitroglycerin lingual spray reference product (Nitrolingual<sup>®</sup>): a randomized, four-cycle, four-sequence, partially replicated crossover Phase I bioequivalence clinical trial
Yingying Fang, Lu Qi, Yu Wang, et al.
Frontiers in Pharmacology
|
July 3, 2026
Safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of STSA-1002, recombinant anti-human C5a fully human monoclonal antibody, in a randomized, first-in-human phase I study in healthy adults
Yingying Fang, Xiaoqian Wang, Lu Qi, et al.
Medical Oncology (Northwood, London, England)
|
November 23, 2011
Clinical implications of ERβ methylation on sporadic breast cancers in Chinese women
Lin Zhao, Zhaojin Yu, Yunan Li, et al.
Journal of Hematology & Oncology
|
April 29, 2021
HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8<sup>+</sup> T and NK cells: a novel therapeutic tumour vaccine
Zhaojin Yu, Wensi Liu, Ying He, et al.
Journal of Hematology & Oncology
|
September 30, 2021
Correction to: HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8+ T and NK cells: a novel therapeutic tumour vaccine
Zhaojin Yu, Wensi Liu, Ying He, et al.
Antimicrobial Agents and Chemotherapy
|
September 7, 2021
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Monoclonal Antibody (SCTA01) Targeting SARS-CoV-2 in Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, Phase I Study
Yinjuan Li, Lu Qi, Haihong Bai, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 102) with videos related to
Sort By:
Page
of 11
Oncology Reports
|
May 9, 2015
Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer
Zhaojin Yu, Mingli Sun, Feng Jin, et al.
Chemical Science
|
September 2, 2025
Enhancing photoredox catalysis by suppressing back electron transfer with the aid of a spin catalyst
Zhiqiang Dong, Chenli Chen, Lingfang Chen, et al.
Molecular Carcinogenesis
|
January 28, 2014
DNA methyltransferase 1/3a overexpression in sporadic breast cancer is associated with reduced expression of estrogen receptor-alpha/breast cancer susceptibility gene 1 and poor prognosis
Zhaojin Yu, Qinghuan Xiao, Lin Zhao, et al.
Nature Communications
|
November 18, 2025
Cross-regional real-time visualization of systemic physiology and dynamics with 3D panoramic photoacoustic computed tomography (3D-PanoPACT)
Xuanhao Wang, Yuqian Meng, Mingli Sun, et al.
Frontiers in Pharmacology
|
September 15, 2025
Pharmacokinetics and safety of highly variable nitroglycerin lingual spray (NLS) versus US-licensed nitroglycerin lingual spray reference product (Nitrolingual<sup>®</sup>): a randomized, four-cycle, four-sequence, partially replicated crossover Phase I bioequivalence clinical trial
Yingying Fang, Lu Qi, Yu Wang, et al.
Frontiers in Pharmacology
|
July 3, 2026
Safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of STSA-1002, recombinant anti-human C5a fully human monoclonal antibody, in a randomized, first-in-human phase I study in healthy adults
Yingying Fang, Xiaoqian Wang, Lu Qi, et al.
Medical Oncology (Northwood, London, England)
|
November 23, 2011
Clinical implications of ERβ methylation on sporadic breast cancers in Chinese women
Lin Zhao, Zhaojin Yu, Yunan Li, et al.
Journal of Hematology & Oncology
|
April 29, 2021
HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8<sup>+</sup> T and NK cells: a novel therapeutic tumour vaccine
Zhaojin Yu, Wensi Liu, Ying He, et al.
Journal of Hematology & Oncology
|
September 30, 2021
Correction to: HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8+ T and NK cells: a novel therapeutic tumour vaccine
Zhaojin Yu, Wensi Liu, Ying He, et al.
Antimicrobial Agents and Chemotherapy
|
September 7, 2021
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Monoclonal Antibody (SCTA01) Targeting SARS-CoV-2 in Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, Phase I Study
Yinjuan Li, Lu Qi, Haihong Bai, et al.
Page
of 11